foscarbidopa/foslevodopa

CHEBI:CHEBI_756295

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20251231
dosage_form
INJECTION
marketing_start_date
20220412
package_marketing_start_date
20220412
route
SUBCUTANEOUS
labeler_name
AbbVie Inc.
manufacturer_name
AbbVie Inc.
active_ingredient_name
FOSCARBIDOPA
active_ingredient_strength
240 mg/mL
generic_name
foscarbidopa/foslevodopa
brand_name
Vyalev
brand_name_base
Vyalev
product_ndc
0074-0501
application_number
NDA216962
spl_id
c922bbea-eabd-43b8-8fd5-e5dc00fac8d9
package_ndc
0074-0501-01
package_description
7 VIAL, SINGLE-DOSE in 1 CARTON (0074-0501-01) / 10 mL in 1 VIAL, SINGLE-DOSE
rxcui
2695789
unii
37NQZ0J76I
spl_set_id
28e806e4-951c-40a9-9f0c-d0929caf054c
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class